A utilization review of digoxin assays: sampling patterns and use.

Hospital drug monitoring practices often lack standardization. Prior research has shown variability in how clinicians order and interpret drug assays. No prior work had resolved the extent of non-compliance with established criteria for digoxin monitoring. This gap motivated a detailed audit of digoxin assay use in a hospital setting. Existing knowledge includes general guidelines for drug level monitoring, but specifics on adherence were unclear. This study aimed to address the lack of data on compliance with audit criteria. It was already known that drug assays require precise timing and handling. However, the frequency of improper execution remained uncertain.

The objective was to assess how well hospital staff followed established guidelines for digoxin assays. The specific problem involved evaluating the appropriateness of ordering, collecting, and using these assays. This review aimed to identify deviations from standard practices. The motivation stemmed from the need to reduce unnecessary costs and improve patient safety. The study focused on rational indications for assays and proper sample collection. It also examined how often dosage adjustments were made based on results. The goal was to inform hospital policy changes and training initiatives. This approach sought to ensure better adherence to clinical protocols.

An interdepartmental committee developed audit criteria for digoxin assays. These criteria included rational indications, correct sample collection, and appropriate dose adjustments. The study reviewed all patients receiving digoxin during a two-month period. Daily chart reviews were conducted regardless of physician orders for assays. Contributory data included electrolyte levels, renal function, and vital signs. Information on concurrent diseases and drug therapy was also collected. Compliance with audit criteria was evaluated across three categories independently. The audit highlighted gaps in physician communication and sample timing instructions.

Out of 245 evaluations, only 38.4% met all audit criteria. Compliance rates were 66% for rational indication, 73% for correct performance, and 86% for dosage adjustment. In 52% of cases, physicians failed to provide clear instructions for sample timing. Over 94% of results reached physicians or charts within 24 hours. Annual estimated costs for non-compliant assays exceeded $100,900. The audit revealed significant variability in how assays were ordered and used. Most non-compliance occurred in the area of sample collection timing. These findings suggest a need for improved training and procedural changes.

The audit demonstrated widespread non-compliance with digoxin assay guidelines. Authors suggest that changes in hospital procedures and training are necessary. The findings highlight the importance of clear physician instructions for sample timing. The researchers propose that pharmacokinetics services could improve adherence. No prior work had resolved the extent of these procedural gaps. The study emphasizes the need for collaborative services to monitor drug levels. Authors state that current practices may lead to unnecessary costs and suboptimal care. These conclusions align with the observed patterns in audit data.